Inhibiting c-MYC Reduces Growth and Treatment Sensitivity in Childhood Medulloblastoma Cells
Author Information
Author(s): von Bueren André O, Shalaby Tarek, Oehler-Jänne Christoph, Arnold Lucia, Stearns Duncan, Eberhart Charles G, Arcaro Alexandre, Pruschy Martin, Grotzer Michael A
Primary Institution: University Children's Hospital, Zurich, Switzerland
Hypothesis
Does down-regulating c-MYC expression affect the growth and treatment sensitivity of childhood medulloblastoma cells?
Conclusion
Targeting c-MYC in childhood medulloblastoma cells decreases cell growth and reduces sensitivity to chemotherapy and radiation.
Supporting Evidence
- Down-regulation of c-MYC led to reduced cell proliferation and clonogenic growth.
- c-MYC inhibition resulted in decreased sensitivity to ionizing radiation and chemotherapy.
- High levels of c-MYC expression correlated with increased apoptosis in medulloblastoma cells.
Takeaway
Scientists found that lowering a protein called c-MYC helps slow down the growth of certain brain cancer cells in kids and makes them less responsive to treatments like chemotherapy and radiation.
Methodology
The study used small interfering RNA (siRNA) to down-regulate c-MYC expression in various human medulloblastoma cell lines and assessed changes in cell growth, apoptosis, and response to chemotherapy and radiation.
Limitations
The study was conducted in vitro, and the effects of c-MYC targeting in vivo remain to be validated.
Participant Demographics
Human medulloblastoma cell lines derived from patients aged 3–5 years.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website